It has been reported that the protein levels of LAMP-1 and LAMP-2 are increased in the CSF of AD patients, together with other four lysosomal network markers (LC3, Rab3, Rab7, and EEA1) (Armstrong et al., 2014). This evidence concerns the gene LAMP1 and Alzheimer disease.